Cargando…

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia

Chimeric antigen receptor (CAR) T-cell technology has seen a rapid development over the last decade mostly due to the potential that these cells may have in treating malignant diseases. It is a generally accepted principle that very few therapeutic compounds deliver a clinical response without treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomuleasa, Ciprian, Fuji, Shigeo, Berce, Cristian, Onaciu, Anca, Chira, Sergiu, Petrushev, Bobe, Micu, Wilhelm-Thomas, Moisoiu, Vlad, Osan, Ciprian, Constantinescu, Catalin, Pasca, Sergiu, Jurj, Ancuta, Pop, Laura, Berindan-Neagoe, Ioana, Dima, Delia, Kitano, Shigehisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825894/ https://www.ncbi.nlm.nih.gov/pubmed/29515572 http://dx.doi.org/10.3389/fimmu.2018.00239

Ejemplares similares

Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

Correction: Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
por: Pasca, Sergiu, et al.
Publicado: (2020)

Approach to the Adult Acute Lymphoblastic Leukemia Patient
por: Sas, Valentina, et al.
Publicado: (2019)

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients
por: Pasca, Sergiu, et al.
Publicado: (2020)

The Potential Equivalents of TET2 Mutations
por: Pasca, Sergiu, et al.
Publicado: (2021)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

The role of the pathology department in the preanalytical phase of molecular analyses
por: Susman, Sergiu, et al.
Publicado: (2018)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
por: Desmirean, Minodora, et al.
Publicado: (2020)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020)

The new era of nanotechnology, an alternative to change cancer treatment
por: Jurj, Ancuta, et al.
Publicado: (2017)

Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis
por: Teodorescu, Patric, et al.
Publicado: (2020)

Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
por: Dobrowolski, Jerome, et al.
Publicado: (2019)

Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
por: Moisoiu, Vlad, et al.
Publicado: (2019)

The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging Biomarkers in Oral Cancer Management
por: Osan, Ciprian, et al.
Publicado: (2021)

The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care Unit
por: Constantinescu, Catalin, et al.
Publicado: (2021)

The use of rotation to fentanyl in cancer-related pain
por: Dima, Delia, et al.
Publicado: (2017)

Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone
por: Constantinescu, Catalin, et al.
Publicado: (2022)

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie, Florin, et al.
Publicado: (2015)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

A narrative review of central nervous system involvement in acute leukemias
por: Deak, Dalma, et al.
Publicado: (2021)

Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions
por: Constantinescu, Catalin, et al.
Publicado: (2023)

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev, Bobe, et al.
Publicado: (2016)

A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells
por: Jurj, Ancuta, et al.
Publicado: (2020)

Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death
por: Chira, Sergiu, et al.
Publicado: (2018)

Correlation between the prevalence of T-cell lymphomas and alcohol consumption
por: Desmirean, Minodora, et al.
Publicado: (2021)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
por: Griesel, Carla, et al.
Publicado: (2020)

SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
por: Moisoiu, Vlad, et al.
Publicado: (2021)

In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
por: Berce, Cristian, et al.
Publicado: (2016)

MRI-based identification of undifferentiated cells: looking at the two faces of Janus
por: Tomuleasa, Ciprian, et al.
Publicado: (2014)

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
por: Gulei, Diana, et al.
Publicado: (2018)

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician
por: Constantinescu, Catalin, et al.
Publicado: (2019)

Topical Corticosteroids a Viable Solution for Oral Graft versus Host Disease? A Systematic Insight on Randomized Clinical Trials
por: Sava, Arin, et al.
Publicado: (2020)

Medical Application of Hydrogen in Hematological Diseases
por: Qian, Liren, et al.
Publicado: (2019)

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma
por: Deak-Mihaly, Dalma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tomgbn53ftpeah2s6ae3akvhib